Filing Details

Accession Number:
0000899243-22-014804
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-14 16:35:05
Reporting Period:
2022-04-12
Accepted Time:
2022-04-14 16:35:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1334365 Yuchun Lee C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-04-12 2,000 $81.54 3,875 No 4 M Direct
Common Stock Disposition 2022-04-12 200 $279.22 3,675 No 4 S Direct
Common Stock Disposition 2022-04-12 1,182 $280.61 2,493 No 4 S Direct
Common Stock Disposition 2022-04-12 318 $281.70 2,175 No 4 S Direct
Common Stock Disposition 2022-04-12 300 $283.15 1,875 No 4 S Direct
Common Stock Acquisiton 2022-04-13 2,000 $81.54 3,875 No 4 M Direct
Common Stock Disposition 2022-04-13 18 $281.49 3,857 No 4 S Direct
Common Stock Disposition 2022-04-13 300 $283.73 3,557 No 4 S Direct
Common Stock Disposition 2022-04-13 228 $284.90 3,329 No 4 S Direct
Common Stock Disposition 2022-04-13 300 $286.24 3,029 No 4 S Direct
Common Stock Disposition 2022-04-13 200 $287.42 2,829 No 4 S Direct
Common Stock Disposition 2022-04-13 400 $288.55 2,429 No 4 S Direct
Common Stock Disposition 2022-04-13 200 $290.17 2,229 No 4 S Direct
Common Stock Disposition 2022-04-13 354 $291.12 1,875 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-04-12 2,000 $0.00 2,000 $81.54
Common Stock Stock Option (Right to Buy) Disposition 2022-04-13 2,000 $0.00 2,000 $81.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,000 2023-05-31 No 4 M Direct
4,000 2023-05-31 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
  2. Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  3. Open market sales reported on this line occurred at a weighted average price of $279.22 (range $279.14 to $279.30).
  4. Open market sales reported on this line occurred at a weighted average price of $280.61 (range $280.24 to $281.19).
  5. Open market sales reported on this line occurred at a weighted average price of $281.70 (range $281.45 to $281.98).
  6. Open market sales reported on this line occurred at a weighted average price of $283.15 (range $282.73 to $283.57).
  7. Open market sales reported on this line occurred at a weighted average price of $283.73 (range $283.30 to $284.10).
  8. Open market sales reported on this line occurred at a weighted average price of $284.90 (range $284.66 to $284.95).
  9. Open market sales reported on this line occurred at a weighted average price of $286.24 (range $285.99 to $286.60).
  10. Open market sales reported on this line occurred at a weighted average price of $287.42 (range $287.02 to $287.83).
  11. Open market sales reported on this line occurred at a weighted average price of $288.55 (range $288.23 to $289.11).
  12. Open market sales reported on this line occurred at a weighted average price of $290.17 (range $289.72 to $290.62).
  13. Open market sales reported on this line occurred at a weighted average price of $291.12 (range $290.80 to $291.42).
  14. Fully vested.